Masimo Corp
MASI139.150USD
+3.820+2.82%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
7.39BMarket Cap
LossP/E TTM
More Details of Masimo Corp Company
Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
Masimo Corp Info
Ticker SymbolMASI
Company nameMasimo Corp
IPO dateAug 08, 2007
CEOSzyman (Catherine M)
Number of employees3600
Security typeOrdinary Share
Fiscal year-endAug 08
Address52 Discovery
CityIRVINE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code92618
Phone19492977000
Websitehttps://www.masimo.com/
Ticker SymbolMASI
IPO dateAug 08, 2007
CEOSzyman (Catherine M)
Company Executives of Masimo Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Blair Tripodi
Mr. Blair Tripodi
Chief Operating Officer - Consumer Division
Chief Operating Officer - Consumer Division
15.54K
+6922.00%
Mr. Eli Kammerman
Mr. Eli Kammerman
Investor Relations Officer
Investor Relations Officer
--
--
Mr. Micah Wesley Young
Mr. Micah Wesley Young
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Michelle M. Brennan
Ms. Michelle M. Brennan
Chairman of the Board
Chairman of the Board
--
--
Mr. Quentin Koffey
Mr. Quentin Koffey
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
--
--
Dr. Darlene Solomon
Dr. Darlene Solomon
Independent Director
Independent Director
--
--
Mr. Timothy J. (Tim) Scannell
Mr. Timothy J. (Tim) Scannell
Independent Director
Independent Director
--
--
Ms. Wendy E. Lane
Ms. Wendy E. Lane
Independent Director
Independent Director
--
--
Ms. Catherine M. (Katie) Szyman
Ms. Catherine M. (Katie) Szyman
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Tim Benner
Mr. Tim Benner
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Blair Tripodi
Mr. Blair Tripodi
Chief Operating Officer - Consumer Division
Chief Operating Officer - Consumer Division
15.54K
+6922.00%
Mr. Eli Kammerman
Mr. Eli Kammerman
Investor Relations Officer
Investor Relations Officer
--
--
Mr. Micah Wesley Young
Mr. Micah Wesley Young
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Michelle M. Brennan
Ms. Michelle M. Brennan
Chairman of the Board
Chairman of the Board
--
--
Mr. Quentin Koffey
Mr. Quentin Koffey
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
--
--
Dr. Darlene Solomon
Dr. Darlene Solomon
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2024
FY2023
FY2022
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
1.13B
53.84%
Europe, Middle East and Africa
595.60M
28.44%
Asia and Australia
303.50M
14.49%
North and South America (excluding the U.S.)
67.70M
3.23%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, Nov 30
Updated: Sun, Nov 30
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
12.88%
Politan Capital Management, L.P.
8.54%
The Vanguard Group, Inc.
8.08%
BlackRock Institutional Trust Company, N.A.
8.02%
BlackRock Investment Management (UK) Ltd.
5.61%
Other
56.87%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
12.88%
Politan Capital Management, L.P.
8.54%
The Vanguard Group, Inc.
8.08%
BlackRock Institutional Trust Company, N.A.
8.02%
BlackRock Investment Management (UK) Ltd.
5.61%
Other
56.87%
Shareholder Types
Shareholders
Proportion
Investment Advisor
54.68%
Investment Advisor/Hedge Fund
32.53%
Hedge Fund
13.45%
Individual Investor
5.75%
Research Firm
3.52%
Pension Fund
1.04%
Bank and Trust
0.39%
Venture Capital
0.18%
Sovereign Wealth Fund
0.14%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
827
56.90M
105.94%
-6.07M
2025Q3
847
60.04M
111.77%
-4.36M
2025Q2
937
59.97M
110.39%
-7.53M
2025Q1
981
59.62M
109.96%
-8.22M
2024Q4
950
56.99M
105.70%
-7.11M
2024Q3
945
55.24M
103.11%
-8.43M
2024Q2
962
54.27M
102.01%
-12.67M
2024Q1
1002
56.30M
106.05%
-9.64M
2023Q4
1090
55.26M
104.56%
-6.33M
2023Q3
1093
52.14M
98.67%
-6.57M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
6.92M
12.88%
-25.87K
-0.37%
Sep 30, 2025
Politan Capital Management, L.P.
4.59M
8.54%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
4.80M
8.93%
+171.32K
+3.70%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
4.31M
8.02%
+70.24K
+1.66%
Sep 30, 2025
BlackRock Investment Management (UK) Ltd.
3.02M
5.61%
-61.18K
-1.99%
Sep 30, 2025
Kiani (Joe E)
2.87M
5.34%
-245.80K
-7.90%
Sep 30, 2025
MFS Investment Management
2.61M
4.87%
+149.74K
+6.07%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
2.13M
3.96%
-373.38K
-14.93%
Sep 30, 2025
Capital Research Global Investors
1.85M
3.45%
-1.54K
-0.08%
Sep 30, 2025
BlackRock Financial Management, Inc.
1.61M
3%
-224.33K
-12.22%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Harbor Health Care ETF
4.85%
iShares US Select Equity Active ETF
3.53%
Global X HealthTech ETF
3.3%
First Trust Nasdaq Lux Digi Health Solutions ETF
2.63%
First Trust Indxx Medical Devices ETF
1.95%
State Street SPDR S&P Health Care Equipment ETF
1.72%
Langar Global HealthTech ETF
1.72%
ROBO Global Healthcare Technology & Innovation ETF
1.27%
Tema Heart & Health ETF
1.24%
Invesco S&P MidCap 400 Pure Growth ETF
1.18%
View more
Harbor Health Care ETF
Proportion4.85%
iShares US Select Equity Active ETF
Proportion3.53%
Global X HealthTech ETF
Proportion3.3%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion2.63%
First Trust Indxx Medical Devices ETF
Proportion1.95%
State Street SPDR S&P Health Care Equipment ETF
Proportion1.72%
Langar Global HealthTech ETF
Proportion1.72%
ROBO Global Healthcare Technology & Innovation ETF
Proportion1.27%
Tema Heart & Health ETF
Proportion1.24%
Invesco S&P MidCap 400 Pure Growth ETF
Proportion1.18%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
